VANGUARD GROUP INC 13D and 13G filings for Intercept Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-10 11:07 am Sale | 2023-09-29 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | VANGUARD GROUP INC | 2,071,222 4.950% | -2,622,585 (-55.87%) | Filing |
| 2023-07-10 10:41 am Purchase | 2023-06-30 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | VANGUARD GROUP INC | 4,693,807 11.260% | 1,055,872 (+29.02%) | Filing |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | VANGUARD GROUP INC | 3,637,935 8.780% | 1,666,176 (+84.50%) | Filing |
| 2022-02-10 08:17 am Sale | 2021-12-31 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | VANGUARD GROUP INC | 1,971,759 6.670% | -1,391,318 (-41.37%) | Filing |
| 2021-06-10 10:06 am Purchase | 2021-05-28 | 13G | INTERCEPT PHARMACEUTICALS INC ICPT | VANGUARD GROUP INC | 3,363,077 10.140% | 534,122 (+18.88%) | Filing |